Longbow Finance SA »

Mink Therapeutics shares owned by Longbow Finance SA

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Longbow Finance SA from 13F filings

Historical chart of Longbow Finance SA investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Longbow Finance SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Longbow Finance SA

Quarter filed Position value Share count Share price at filing
2025-09-30 $233k 17k 14.00
2025-06-30 $123k 17k 7.39

More positions owned by Longbow Finance SA

NVIDIA Corporation Common Stock (NVDA)
Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Class C Capital Stock (GOOG)
Meta Platforms Class A Common Stock (META)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
JPMorgan Chase & Co. Common Stock (JPM)
Exxon Mobil Corporation Common Stock (XOM)
Abbvie Common Stock (ABBV)
Oracle Corporation Common Stock (ORCL)
Arthur J. GallagherA & Co. Common Stock (AJG)
Berkshire Hathaway Class B Common Stock (BRK.B)
AutoZone Common Stock (AZO)
Walmart Common Stock (WMT)

View all positions for Longbow Finance SA

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Renaissance Technologies
Geode Capital Management
BlackRock
UBS Group
Tower Research Capital
Covestor
Advisor Group Holdings
Morgan Stanley
Northwestern Mutual Wealth Management Company
Game Plan Financial Advisors
Bnp Paribas Arbitrage, Snc
Hartland & Co
Jpmorgan Chase & Co

View all funds holding Mink Therapeutics